A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers
A randomized, open-label, single dose, crossover clinical trial
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
administration of Metformin + Rosuvastatin
administration of JLP-1310
Inha University Hospital
Incheon, South Korea
AUClast of Metformin and rosuvastatin
Time frame: 48 hours
Cmax of Metformin and rosuvastatin
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.